Avantor (AVTR) Expected to Release Earnings on Wednesday

Avantor (NYSE:AVTR) is projected to post its Q3 2026 results before the market opens on Wednesday, October 28th. Analysts expect Avantor to post earnings of $0.2092 per share and revenue of $1.64 billion for the quarter. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS. Parties may visit the company’s upcoming Q3 2026 earnings results page for the latest details on the call scheduled for Wednesday, October 28, 2026 at 8:00 AM ET.

Avantor (NYSE:AVTR) last posted its quarterly earnings results on Wednesday, July 29th. The company reported $0.21 EPS for the quarter, beating the consensus estimate of $0.19 by $0.02. Avantor had a negative net margin of 8.81% and a positive return on equity of 9.92%. The business had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.61 billion. During the same period in the previous year, the business posted $0.24 EPS. The company’s quarterly revenue was up .5% on a year-over-year basis. On average, analysts expect Avantor to post $0.81 EPS for the current fiscal year and $0.86 EPS for the next fiscal year.

Avantor Price Performance

Shares of NYSE:AVTR opened at $17.30 on Tuesday. The company has a market cap of $11.70 billion, a PE ratio of -20.59, a P/E/G ratio of 9.83 and a beta of 0.94. Avantor has a fifty-two week low of $7.26 and a fifty-two week high of $17.45. The firm has a 50-day simple moving average of $15.19 and a 200 day simple moving average of $11.13. The company has a quick ratio of 1.18, a current ratio of 1.78 and a debt-to-equity ratio of 0.65.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the company. Evercore set a $10.50 target price on Avantor in a report on Monday, July 6th. Morgan Stanley increased their price target on Avantor from $14.00 to $15.00 and gave the stock an “equal weight” rating in a research report on Tuesday, October 13th. Royal Bank Of Canada raised their price target on Avantor from $9.00 to $14.00 and gave the stock a “sector perform” rating in a report on Thursday, July 30th. Citigroup upped their price objective on Avantor from $9.00 to $11.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 8th. Finally, TD Cowen upped their price objective on Avantor from $15.00 to $17.00 and gave the stock a “hold” rating in a research note on Tuesday, October 13th. One research analyst has rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $13.06.

About Avantor

Avantor, Inc is a global provider of mission-critical products and services used in the life sciences, healthcare, education, and advanced technology industries. The company supplies chemicals, reagents, laboratory consumables, equipment, and other materials used in research, development, manufacturing, and quality-control activities.

Avantor also provides specialized solutions for biopharmaceutical production, including materials and services that support drug development, biologics manufacturing, and other bioprocessing applications.